Parry–Romberg syndrome
(Redirected from Parry-Romberg syndrome)
Parry–Romberg syndrome (PRS), also known as progressive hemifacial atrophy, is a rare disorder characterized by the progressive deterioration (atrophy) of the skin and soft tissues of half of the face. This condition typically affects the left side of the face, but it can also affect the right side or, in rare cases, both sides. The syndrome is named after Caleb Hillier Parry and Moritz Heinrich Romberg, who first described the condition in the 19th century.
Signs and Symptoms[edit | edit source]
The primary feature of Parry–Romberg syndrome is the slow, progressive atrophy of the skin and soft tissues on one side of the face. This atrophy can affect the muscles, fat, and bones, leading to a sunken appearance. Other symptoms may include:
- Facial pain or headaches
- Trigeminal neuralgia
- Seizures
- Enophthalmos (sunken eye)
- Alopecia (hair loss) on the affected side
- Hyperpigmentation or hypopigmentation of the skin
Causes[edit | edit source]
The exact cause of Parry–Romberg syndrome is unknown. Several theories have been proposed, including:
Diagnosis[edit | edit source]
Diagnosis of Parry–Romberg syndrome is primarily clinical, based on the characteristic signs and symptoms. Imaging studies such as MRI or CT scan may be used to assess the extent of tissue atrophy and to rule out other conditions. Biopsy of affected tissues is rarely necessary but can be performed to exclude other diagnoses.
Treatment[edit | edit source]
There is no cure for Parry–Romberg syndrome, and treatment is primarily symptomatic. Options may include:
- Physical therapy to maintain muscle function
- Pain management for facial pain and headaches
- Anticonvulsants for seizures
- Reconstructive surgery to address cosmetic concerns
Prognosis[edit | edit source]
The progression of Parry–Romberg syndrome varies among individuals. In some cases, the atrophy may stabilize after a few years, while in others, it may continue to progress. The condition is not life-threatening, but it can have significant psychological and social impacts due to facial disfigurement.
Related Pages[edit | edit source]
Categories[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD